We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVR icon
226
NVR
NVR
$17.2B
$7.06M 0.11%
2,378
+2,138
+891% +$6.54M
BN icon
227
Brookfield
BN
$102B
$7.01M 0.11%
484,315
+314,680
+186% +$4.49M
WBC
228
DELISTED
WABCO HOLDINGS INC.
WBC
$6.99M 0.11%
59,728
+965
+2% +$123K
IYR icon
229
iShares US Real Estate ETF
IYR
$4.59B
$6.99M 0.11%
86,694
-9,239
-10% -$712K
OLED icon
230
Universal Display
OLED
$3.71B
$6.96M 0.11%
+80,987
New +$7.72M
KURA icon
231
Kura Oncology
KURA
$922M
$6.95M 0.11%
382,000
-3,000
-0.8% -$50.8K
MPC icon
232
Marathon Petroleum
MPC
$90.3B
$6.95M 0.11%
99,025
+14,284
+17% +$1.09M
CHTR icon
233
Charter Communications
CHTR
$14.7B
$6.93M 0.11%
23,623
+4,035
+21% +$1.16M
ITUB icon
234
Itaú Unibanco
ITUB
$91.3B
$6.92M 0.11%
1,373,934
+460,538
+50% +$2.86M
TGT icon
235
Target
TGT
$62.1B
$6.81M 0.11%
89,431
+16,812
+23% +$1.24M
GS icon
236
Goldman Sachs
GS
$313B
$6.8M 0.11%
30,816
+9,585
+45% +$2.29M
INFO
237
DELISTED
IHS Markit Ltd. Common Shares
INFO
$6.78M 0.11%
131,365
-191,553
-59% -$9.59M
PCG icon
238
PG&E
PCG
$47.8B
$6.76M 0.11%
158,753
+75,089
+90% +$3.26M
IMGN
239
DELISTED
Immunogen Inc
IMGN
$6.75M 0.11%
694,000
+100,000
+17% +$1.05M
QRVO icon
240
Qorvo
QRVO
$7.63B
$6.75M 0.11%
84,127
+39,030
+87% +$3.02M
NKTR icon
241
Nektar Therapeutics
NKTR
$2.39B
$6.68M 0.11%
+9,119
New +$10.5M
CVS icon
242
CVS Health
CVS
$137B
$6.64M 0.11%
103,165
+8,519
+9% +$561K
EWC icon
243
iShares MSCI Canada ETF
EWC
$6.04B
$6.63M 0.11%
232,666
-11,276
-5% -$321K
HOG icon
244
Harley-Davidson
HOG
$2.68B
$6.58M 0.1%
156,445
+85,575
+121% +$3.61M
COST icon
245
Costco
COST
$415B
$6.55M 0.1%
31,358
-5,808
-16% -$1.15M
ADP icon
246
Automatic Data Processing
ADP
$100B
$6.54M 0.1%
48,784
+472
+1% +$59.8K
RARE icon
247
Ultragenyx Pharmaceutical
RARE
$2.65B
$6.53M 0.1%
85,000
-6,000
-7% -$388K
IONS icon
248
Ionis Pharmaceuticals
IONS
$9.35B
$6.49M 0.1%
155,800
+13,800
+10% +$612K
ATVI
249
DELISTED
Activision Blizzard
ATVI
$6.41M 0.1%
84,000
+1,206
+1% +$85.3K
ONC
250
BeOne Medicines Ltd
ONC
$33.8B
$6.38M 0.1%
41,500
+6,500
+19% +$1.16M
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.